Works matching IS 14397595 AND DT 2020 AND VI 30 AND IP 5


Results: 22
    1
    2
    3
    4
    5
    6

    Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.

    Published in:
    Modern Rheumatology, 2020, v. 30, n. 5, p. 807, doi. 10.1080/14397595.2019.1676369
    By:
    • Yasuharu Nakashima;
    • Masakazu Kondo;
    • Eisuke Shono;
    • Takashi Ishinishi;
    • Hiroshi Tsukamoto;
    • Koji Kuroda;
    • Akira Maeyama;
    • Hiroshi Harada;
    • Masayuki Maekawa;
    • Takashi Shimauchi;
    • Ryuji Nagamine;
    • Hiroshi Jojima;
    • Seiji Yoshizawa;
    • Tomomi Tsuru;
    • Takeshi Otsuka;
    • Hisaaki Miyahara;
    • Eiichi Suematsu;
    • Ken Wada;
    • Shigeru Yoshizawa;
    • Yasushi Inoue
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.

    Published in:
    Modern Rheumatology, 2020, v. 30, n. 5, p. 852, doi. 10.1080/14397595.2019.1661592
    By:
    • Sayaka Tsuda;
    • Azusa Sameshima;
    • Michikazu Sekine;
    • Haruna Kawaguchi;
    • Daisuke Fujita;
    • Shintaro Makino;
    • Akio Morinobu;
    • Yohko Murakawa;
    • Kiyoshi Matsui;
    • Takao Sugiyama;
    • Mamoru Watanabe;
    • Yasuo Suzuki;
    • Masakazu Nagahori;
    • Atsuko Murashima;
    • Tatsuya Atsumi;
    • Kenji Oku;
    • Nobuaki Mitsuda;
    • Syuji Takei;
    • Takako Miyamae;
    • Naoto Takahashi
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22